Clinical Trials Directory

Trials / Completed

CompletedNCT00932919

Thought Field Therapy and Cognitive Therapy for Agoraphobia

Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Sorlandet Hospital HF · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Detailed description

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies. Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment. All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThought field therapy5 sessions with Thought field therapy
BEHAVIORALCognitive therapy12 sessions of Cognitive therapy
BEHAVIORALWait list3 months waiting, then randomized to either thought field therapy or cognitive therapy

Timeline

Start date
2006-10-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2009-07-07
Last updated
2014-04-23

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00932919. Inclusion in this directory is not an endorsement.